BIO.BE

bio.be is the Belgian federation of companies active in life sciences and biotechnologies. It is part of essenscia, the Belgian federation for chemistry and life sciences industries.

In its advocacy role, bio.be/essenscia represents the interests of its members as regards to legislation and standards at various policy levels (Belgium, EU, OECD).
In its communication role, the federation promotes the excellence of its members to deliver innovative products, services and technologies for a better life for today and for the future.

The mission of bio.be/essenscia is to foster a supportive environment and a stable legal framework in line with the trend for innovation, an essential factor for:
  • the economic sustainability and employment growth in the sector;
  • the capability of this sector to answer major societal challenges.
bio.be/essenscia can rely on synergies within the essenscia group, including with the regional branches essenscia wallonia, essenscia brussels and essenscia vlaanderen as well as with the products’ sectors such as Pharma.be. It has also access to the expertise of its extensive network of partners. bio.be/essenscia is, for example, the Belgian national association contact point for EuropaBio, the European association for bioindustries, and is also member of ICBA, the International Council of Biotechnology Associations jointly created by BIO and EuropaBio.

Big data in life Sciences in R&D 24 November 2017




Programme

14:00-14:30: Registration and Coffee
Chairs: Jean-Michel Foidart (ARMB) and Greet Ieven (KAGB)
Moderators: Frédéric Druck (bio.be, essenscia) and Carole Absil (Agoria)
14:30: Ruth Laub (Chair of FBBF): Introductive words
14:35: Jonathan Van Eyll (UCB): “Connected sciences: From science to patients value/ From patients to science”
14:55: Bart Vannieuwenhuyse (Janssen Pharma): “Connected organizations: EMIF (IMI): E-managing the future of health data”
15:15: Jean-Pol Detiffe (OncoDNA): “Connected patients: Connecting oncologists and connecting patients to improve cancer precision medicine”
15:35: Marc Martens (Bird&Bird): “Data Protection: Health data management and the new EU General Data Protection Regulation”
15:55: Panel debate with the speakers animated by Carole Absil and Frédéric Druck
16:20: FBBF Awards Ceremony and presentation of the 2 awarded works
16:50: Reception


Click here to register

Annual event bio.be 26 September 2017 - "Life sciences and biotechnologies in Belgium - Growth! Growth! Growth

Board members

Name    Company
Tineke Van hooland ABBVIE (Chair)
Dirk Carrez Cleverconsult
Marleen Hoebus Amgen
Xavier Hormachea UCB
Elke Janssen NautaDutilh
Patrick Jeanmart Celyad
Luc Kupers Genzyme
Pascal Lizin GSK
Marc Martens Bird & Bird
Patrick Rüdelsheim Perseus
Annie Van Broekhoven Q Biologicals
Bert Van Loo Genencor/Dupont